CASP9 and plasma cell myeloma: In an in vitro study, it has been demonstrated that oprozomib inhibits growth and migration of myeloma cell lines and induces apoptosis through the activation of caspase-8, caspase-9 and caspase-3 and poly(ADP) ribose polymerase (PARP) [104].